Deinove on Track to Receive Key Biomaterials Patent

Deinove (Paris), a biotech start-up, says the European Patent Office (EPO) has sent the company an “intention to grant" notice for a “foundational” biomaterials patent relating to the exploitation of deinococcus bacteria.   The patent covers a genetic engineering process invented by Deinove, which exploits deinococci's unique self-repair ability - a property which has enabled these bacteria to enrich their genome through natural evolution over 3 billion years, the company says. The self-repair characteristic has enabled the bacteria to...

Already an IHS Chemical Week member?
Login here

Forgot your user ID or password?
Click here to have it sent to you.

Click here for 6 months access to the lates news, data and statistics on sustainability.  PLUS all the news and analysis from the Chemical Week editorial team updated everyday on IHS Chemical Week